ACTRN12619000317190招募中未知
Clinical Trial examining the sensitivity and specificity of Gazefinder for identifying young children with autism
a Trobe University0 个研究点目标入组 200 人开始时间: 2019年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 24 Months 至 59 Months（—）
- 性别
- All
入选标准
- •Children with autism: Aged between 2 years 0 months and 4 years 11 months, with diagnosis of autism from a community professional (evidenced through provision of copy of report/letter).
- •Typically Developing (TD) children: Aged between 2 years 0 months and 4 years 11 months
排除标准
- •Children with autism: Uncorrected visual/hearing impairment
- •Typically developing (TD) children: Uncorrected visual/hearing; parent-reported family history of autism among first-degree relatives (parent/s and/or sibling/s); presence of another developmental condition and/or moderate-level autism behaviours (operationalised as score >12 on Social Communication Questionnaire).
研究者
相似试验
招募中
2 期
Sensitivity and specificity of three-point compression ultrasonography in diagnosis of deep vein thrombosisDeep vein thrombosis.Phlebitis and thrombophlebitis of other deep vessels of lower extremitiesIRCT20190309042978N1Sari University of Medical Sciences70
已完成
2 期
CHAMP: Clearing High Risk HPV Among Men who have sex with Men PilotACTRN12617001355369The Alfred31
已完成
不适用
Clinical Trial for evaluation of the clinical effect of on line hemodiafiltration (HDF) and beta2-microglobulin adsorption column combination therapy.JPRN-UMIN000009429Hyogo College of Medicine40
已完成
2 期
Clinical study to investigate safety, tolerability, efficacy,pharmacokinetics and pharmacodynamics of inhaled multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD– A randomised, double-blind, parallel group, multicenter, phase IIa pilot study –J44.9Chronic obstructive pulmonary disease, unspecifiedDRKS00006087Philipps-Universität Marburg19
进行中（未招募）
不适用
Clinical study to investigate safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with mild allergic asthmaEUCTR2012-003570-77-DEsterna biologicals GmbH & Co. KG